Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.22 CHF | -0.35% | -2.09% | -0.67% |
12:33am | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 18 | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.67% | 203B | |
+27.97% | 672B | |
+23.58% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.42% | 211B | |
-10.18% | 194B | |
-11.81% | 144B | |
-8.80% | 141B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Wolfe Research Downgrades Novartis to Peer Perform From Outperform